Biotech Archives | the deep dive

Pfizer-BioNTech Set To Supply The US Government With 105 Million COVID-19 Vaccine For US$3.2 Billion

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced on Wednesday a new vaccine supply agreement with the US

Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it applies for a Nasdaq Capital

On June 5, Dr. Luis Diaz of NYC-based Memorial Sloan Kettering Cancer Center, perhaps the most well-regarded cancer treatment center

It seems CytoDyn Inc. (OTCQB: CYDY) is ready to extend an olive branch to its former chief medical officer. The

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on the Nasdaq Capital Market. The

Sona Nanotech (CSE: SONA) last night finally announced it is waving the white flag on its COVID-19 rapid saliva test.

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced today the topline results from the phase 1 clinical

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced today that its top collaborators have released positive topline

Pond technologies (CSE: POND) continues to see success within its biotech division. The company this morning indicated it ahs seen

Biopharmaceutical company PepGen, Inc. (Nasdaq: PEPG) began trading on the Nasdaq Global Select Market on Friday. The firm’s initial public